US Edition
Caveolin-1 Gene Therapy Reduces Cognitive Decline in an Alzheimer's Mouse Model
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.3 Articles
3 Articles
Caveolin-1 Gene Therapy Reduces Cognitive Decline in an Alzheimer's Mouse Model
Researchers here assess a compensatory approach to the neurodegeneration of Alzheimer's disease, meaning an enhancement of the ability of cells to operate in the face of damage rather than addressing the damage itself. This can inevitably only slow progression of the condition, and is not a path to a curative therapy. Nonetheless, tinkering with cell metabolism in order to slow disease progression is arguably the dominant approach to the develop…
Alzheimer's disease is considered to be a frightening plague of aging. In Germany, about 1.8 million people are currently affected by dementia, two thirds of whom suffer from Alzheimer's disease. The number of people affected is increasing — a dramatic development. Protecting the brain with Alzheimer's disease!* But there is also hope: Natural remedies, nutrition, antioxidants and a healthy lifestyle can help prevent Alzheimer's disease, which […
NEWS FROM THE RESEARCH FRONT: Every week, Ekstra Bladet takes you on a tour of the research corridor, where we review the most important results for you and your health. This time, it's about how researchers in a new study have shown how you can easily reduce your risk of Alzheimer's.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
